Compare with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIAN HEALTHCARE vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIAN HEALTHCARE GSK PHARMA CIAN HEALTHCARE/
GSK PHARMA
 
P/E (TTM) x - 61.1 - View Chart
P/BV x 0.7 20.2 3.3% View Chart
Dividend Yield % 0.0 1.7 -  

Financials

 CIAN HEALTHCARE   GSK PHARMA
EQUITY SHARE DATA
    CIAN HEALTHCARE
Mar-20
GSK PHARMA
Mar-21
CIAN HEALTHCARE/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs631,805 3.5%   
Low Rs121,155 1.1%   
Sales per share (Unadj.) Rs24.4188.8 12.9%  
Earnings per share (Unadj.) Rs-1.621.1 -7.7%  
Cash flow per share (Unadj.) Rs0.325.8 1.1%  
Dividends per share (Unadj.) Rs030.00 0.0%  
Avg Dividend yield %02.0 0.0%  
Book value per share (Unadj.) Rs24.988.5 28.2%  
Shares outstanding (eoy) m23.36169.41 13.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.57.8 19.6%   
Avg P/E ratio x-23.270.0 -33.1%  
P/CF ratio (eoy) x132.857.3 231.7%  
Price / Book Value ratio x1.516.7 9.0%  
Dividend payout %0141.9 0.0%   
Avg Mkt Cap Rs m878250,695 0.4%   
No. of employees `000NANA-   
Total wages/salary Rs m406,147 0.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m57131,989 1.8%  
Other income Rs m91,106 0.8%   
Total revenues Rs m58033,094 1.8%   
Gross profit Rs m735,227 1.4%  
Depreciation Rs m44793 5.6%   
Interest Rs m7235 204.4%   
Profit before tax Rs m-355,505 -0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m31,924 0.1%   
Profit after tax Rs m-383,581 -1.1%  
Gross profit margin %12.716.3 78.0%  
Effective tax rate %-7.534.9 -21.4%   
Net profit margin %-6.611.2 -59.3%  
BALANCE SHEET DATA
Current assets Rs m76922,027 3.5%   
Current liabilities Rs m50013,325 3.8%   
Net working cap to sales %47.027.2 172.9%  
Current ratio x1.51.7 92.9%  
Inventory Days Days6547 139.5%  
Debtors Days Days128246 51.9%  
Net fixed assets Rs m7968,076 9.9%   
Share capital Rs m2341,694 13.8%   
"Free" reserves Rs m34813,297 2.6%   
Net worth Rs m58214,991 3.9%   
Long term debt Rs m4580-   
Total assets Rs m1,56430,102 5.2%  
Interest coverage x0.5156.9 0.3%   
Debt to equity ratio x0.80-  
Sales to assets ratio x0.41.1 34.3%   
Return on assets %2.212.0 18.2%  
Return on equity %-6.523.9 -27.2%  
Return on capital %3.537.0 9.6%  
Exports to sales %9.00-   
Imports to sales %0.10.9 9.9%   
Exports (fob) Rs m52NA-   
Imports (cif) Rs mNA276 0.2%   
Fx inflow Rs m52278 18.6%   
Fx outflow Rs m0276 0.2%   
Net fx Rs m512 2,165.3%   
CASH FLOW
From Operations Rs m-845,779 -1.5%  
From Investments Rs m-2744,186 -6.6%  
From Financial Activity Rs m369-6,961 -5.3%  
Net Cashflow Rs m103,004 0.3%  

Share Holding

Indian Promoters % 70.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 12.6 -  
FIIs % 0.0 1.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 25.0 116.4%  
Shareholders   385 121,445 0.3%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIAN HEALTHCARE With:   DENIS CHEM LAB  BERYL DRUGS  VENUS REMEDIES  GLENMARK PHARMA  BIOCON   



Today's Market

Sensex Jumps 550 Points, Nifty Above 17,000; Metal & Banking Stocks Rally(10:30 am)

Asian stock markets are higher today as investors took heart from strong rebounds on Wall Street on hopes that the newest coronavirus variant will prove less virulent than earlier strains.

Related Views on News

GSK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GSK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CIAN HEALTHCARE SHARE PRICE


Dec 7, 2021 03:26 PM

TRACK CIAN HEALTHCARE

  • Track your investment in CIAN HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CIAN HEALTHCARE

CIAN HEALTHCARE 8-QTR ANALYSIS

COMPARE CIAN HEALTHCARE WITH

MARKET STATS